Tenafly, NJ, United States of America

Kenneth W Lieberman

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: New Jersey Institute of Technology. Active years: 2014.


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kenneth W. Lieberman in Fiber Optic Technology

Introduction

Kenneth W. Lieberman is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of fiber optic technology, particularly in the area of medical applications. His innovative work focuses on integrating fiber optic Raman spectroscopy with radio frequency ablation to enhance the detection and treatment of diseased tissues.

Latest Patents

Kenneth W. Lieberman holds 1 patent for his invention titled "Integrated Fiber Optic Raman Spectroscopy and Radio Frequency Ablation." This technology is designed to detect diseased tissues through fiber optic-based Raman spectroscopy, image acquisition, and RF-induced hyperthermia treatment. The invention utilizes a fiber optic bundle that carries optical and RF signals, allowing for effective spectroscopy, visual imaging, and RF ablation. The system is capable of monitoring the temperature of treated tissues, enabling precise control over the RF signal for optimal treatment outcomes.

Career Highlights

Kenneth W. Lieberman is affiliated with the New Jersey Institute of Technology, where he continues to advance research in fiber optic technologies. His work has implications for improving medical diagnostics and treatment methodologies, showcasing his commitment to innovation in healthcare.

Collaborations

One of his notable collaborators is Edip Niver, with whom he has worked on various projects related to fiber optics and medical applications.

Conclusion

Kenneth W. Lieberman's contributions to fiber optic technology exemplify the intersection of innovation and healthcare. His patented technology has the potential to significantly improve the detection and treatment of diseases, highlighting the importance of continued research and development in this field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…